Pfizer Inc.’s Prevnar 13 vaccine for a bacterial infection that causes pneumonia won the backing of a U.S. advisory panel today for use in adults 50 and older.... Pfizer's Prevnar 13 Wins Panel Backing for Older Adults - Businessweek
The Prevnar 13 vaccine has been available since March 2010, when it replaced the older version of Prevnar, which only protected against 7 pneumococcal serotypes. Prevnar 13 Vaccine Reminder
Common Childhood Vaccination Promotes New Superbug: The use of the vaccine Prevnar, which has successfully curbed pneumonia, meningitis, and deadly bloodstream infections in young children for the past seven years, has now unleashed a superbug that is resistant to all currently available drugs. ... Many vaccines were developed for use in 3rd World countries, and now are “offered” here to help the vaccine-maker’s bottom line. The idea is also that we are fast becoming a 3rd World country ourselves.Vaccines: Common vaccine spawns superbug | Carolyn Yeager
I didn't notice any mention of Prevnar in the database.